Current Projects & Status
Discovery/Validation
IND-enabling studies
Phase 1
Phase 2/3
TT001 for cisplatin- and noise-induced hearing loss
TT002 for cisplatin- and noise-induced hearing loss
TT003 for for aminoglycoside-induced hearing loss
TT004 for cisplatin- and noise-induced hearing loss
TT005 for noise-induced hearing loss